Florence Crittenton Home and Services
-
Services:
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Outcome follow-up after discharge
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Screening for substance use
- Comprehensive substance use assessment
- Comprehensive mental health assessment
- Screening for mental disorders
- Complete medical history/physical exam
- Screening for tobacco use
- Outreach to persons in the community
- Interim services for clients
- Pregnant/postpartum women
- Medication routinely used during detoxification
- Methamphetamines detoxification
- Cocaine Detoxification
- Benzodiazepines Detoxification
- Opioids detoxification
- Prescribes naltrexone
- Buprenorphine maintenance
- Buprenorphine detoxification
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Family counseling
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- Substance use disorder education
- Individual counseling
- Suicide prevention services
- Social skills development
- Case management service
- Residential beds for clients’ children
- Domestic violence services, including family or partner
- Mental health services
- Child care for clients’ children
- Other contracted prescribing entity
- In-network prescribing entity
- Federal, or any government funding for substance use treatment programs
- SAMHSA funding/block grants
- Medicaid
- Cash or self-payment
- Private health insurance
- Seniors
- Adults
- Male
- Female
- State Substance use treatment agency
- National Committee for Quality Assurance (NCQA)
- Federally Qualified Health Center
- State department of health
- State mental health department
- The Joint Commission
- Residential detoxification
- Regular outpatient treatment
- Residential/24-hour residential
- Long-term residential
- Outpatient
- Detoxification
- Substance use treatment
- Transitional housing, halfway house, or sober home
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Vaping not permitted
- Private non-profit organization
- Naltrexone (extended-release, injectable)
- Clonidine
- Nicotine replacement
- Non-nicotine smoking/tobacco cessation
- Buprenorphine with naloxone
- Naltrexone (oral)
- Acamprosate (Campral®)
- Buprenorphine without naloxone
- Medication for mental disorders
- Disulfiram
- Self-help groups
- Assistance with obtaining social services
- Employment counseling or training
- Mentoring/peer support
- Housing services
- Smoking not permitted
- Telemedicine/telehealth therapy
- 12-step facilitation
- Substance use disorder counseling
- Motivational interviewing
- Contingency management/motivational incentives
- Brief intervention
- Trauma-related counseling
Transitional Services
Opioid Medications used in Treatment
Type of Alcohol Use Disorder Treatment
Testing
Assessment/Pre-treatment
Special Programs/Groups Offered
Detoxification (medical withdrawal) Services
Type of Opioid Treatment
Education and Counseling Services
Ancillary Services
External Opioid Medications Source
External Source of Medications Used for Alcohol Use Disorder Treatment
Payment/Insurance/Funding Accepted
Age Groups Accepted
Gender Accepted
License/Certification/Accreditation
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Type of Care
Facility Vaping Policy
Facility Operation (e.g., Private, Public)
Pharmacotherapies
Recovery Support Services
Facility Smoking Policy
Treatment Approaches